Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28040505 | 0.90 | PTGS2 (0.36) | PTGS2CYP3A4GPR84TDP1L3MBTL1 | |
| SCHEMBL27887334 | 0.88 | PTGS2 (0.36) | PTGS2CYP3A4GPR84SPHK1TDP1 | |
| SCHEMBL28040440 | 0.83 | — | — | |
| SCHEMBL28040405 | 0.82 | PTGS2 (0.40) | PTGS2CYP3A4GPR84TDP1L3MBTL1 | |
| SCHEMBL28040393 | 0.81 | PTGS2 (0.39) | PTGS2CYP3A4GPR84TDP1L3MBTL1 | |
| SCHEMBL27953356 | 0.81 | CA2 (0.35) | PTGS2CYP3A4SPHK1 | |
| SCHEMBL28040577 | 0.81 | PTGS2 (0.39) | PTGS2CYP3A4GPR84TDP1L3MBTL1 | |
| SCHEMBL28040625 | 0.78 | PTGS2 (0.37) | PTGS2CYP3A4GPR84TDP1L3MBTL1 | |
| SCHEMBL27871044 | 0.78 | PTGS2 (0.35) | PTGS2CYP3A4GPR84TDP1L3MBTL1 | |
| SCHEMBL28040787 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102666561-B | Transition metal complex, the cyclopentadiene compound of catalyst for trimerization and replacement | SUMITOMO CHEMICAL CO.,LTD. (JP) | 2015-11-25 | — | — | CN | disclosed |